HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis.

AbstractUNLABELLED:
The recent addition of immunoglobulin (Ig)G4-associated cholangitis (IAC), also called IgG4-related sclerosing cholangitis (IRSC), to the spectrum of chronic cholangiopathies has created the clinical need for reliable methods to discriminate between IAC and the more common cholestatic entities, primary (PSC) and secondary sclerosing cholangitis. The current American Association for the Study of Liver Diseases practice guidelines for PSC advise on the measurement of specific Ig (sIg)G4 in PSC patients, but interpretation of elevated sIgG4 levels remains unclear. We aimed to provide an algorithm to distinguish IAC from PSC using sIgG analyses. We measured total IgG and IgG subclasses in serum samples of IAC (n = 73) and PSC (n = 310) patients, as well as in serum samples of disease controls (primary biliary cirrhosis; n = 22). sIgG4 levels were elevated above the upper limit of normal (ULN = >1.4 g/L) in 45 PSC patients (15%; 95% confidence interval [CI]: 11-19). The highest specificity and positive predictive value (PPV; 100%) for IAC were reached when applying the 4 × ULN (sIgG4 > 5.6 g/L) cutoff with a sensitivity of 42% (95% CI: 31-55). However, in patients with a sIgG4 between 1 × and 2 × ULN (n = 38/45), the PPV of sIgG4 for IAC was only 28%. In this subgroup, the sIgG4/sIgG1 ratio cutoff of 0.24 yielded a sensitivity of 80% (95% CI: 51-95), a specificity of 74% (95% CI: 57-86), a PPV of 55% (95% CI: 33-75), and a negative predictive value of 90% (95% CI: 73-97).
CONCLUSION:
Elevated sIgG4 (>1.4 g/L) occurred in 15% of patients with PSC. In patients with a sIgG4 >1.4 and <2.8 g/L, incorporating the IgG4/IgG1 ratio with a cutoff at 0.24 in the diagnostic algorithm significantly improved PPV and specificity. We propose a new diagnostic algorithm based on IgG4/IgG1 ratio that may be used in clinical practice to distinguish PSC from IAC.
AuthorsKirsten Boonstra, Emma L Culver, Lucas Maillette de Buy Wenniger, Marianne J van Heerde, Karel J van Erpecum, Alexander C Poen, Karin M J van Nieuwkerk, B W Marcel Spanier, Ben J M Witteman, Hans A R E Tuynman, Nan van Geloven, Henk van Buuren, Roger W Chapman, Eleanor Barnes, Ulrich Beuers, Cyriel Y Ponsioen
JournalHepatology (Baltimore, Md.) (Hepatology) Vol. 59 Issue 5 Pg. 1954-63 (May 2014) ISSN: 1527-3350 [Electronic] United States
PMID24375491 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2014 by the American Association for the Study of Liver Diseases.
Chemical References
  • Immunoglobulin G
Topics
  • Adult
  • Aged
  • Cholangitis (diagnosis, immunology)
  • Cholangitis, Sclerosing (diagnosis, immunology)
  • Female
  • Humans
  • Immunoglobulin G (blood, classification)
  • Male
  • Middle Aged
  • Predictive Value of Tests

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: